In a continued effort to bring to you updates in regards to what we have previously blogged could very well be a record-setting-year for Johnson & Johnson with respect to jury verdicts, we wanted to report the latest in our series.
This past week on May 26th, a Philadelphia jury awarded $2.1 million to a woman who suffered serious complications after having an Ethicon (Johnson & Johnson) Gynecare Prolift mesh device surgically inserted.
The verdict is the fourth such verdict in a row against Johnson & Johnson and its Ethicon division in a Pennsylvania transvaginal mesh lawsuit.
Prolift mesh was used to treat stress urinary incontinence and pelvic organ prolapse suffered by the Plaintiff. She asserted at trial that the mesh had eroded into her private areas resulting in permanent complications. The jury deliberated for approximately nine hours before coming to a decision.
The verdict follows a $20 million, $12.5 million and $13.5 million decision in Pennsylvania against Johnson & Johnson and Ethicon, all related to transvaginal mesh.
Our blog will continue to update with additional J&J news, especially as we are closely watching the Xarelto trial that just began against Johnson & Johnson in Florida this past week.
